Mutsunori Murahashi

Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors

Mutsunori Murahashi, Yasuki Hijikata, Kazunari Yamada et al. · Clinical Immunology · 2016 · 62 citations

Medicine, Immunology, Oncology +16

Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis

Kiyomi Shitaoka, Hiroshi Hamana, Hiroyuki Kishi et al. · Cancer Immunology Research · 2018 · 34 citations

Life Sciences, Immunology, Oncology +17

RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer

Hideya Onishi, Shu Ichimiya, Kosuke Yanai et al. · Anticancer Research · 2018 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +13

A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors

Yasuki Hijikata, Toshihiko Okazaki, Yoshihiro Tanaka et al. · PLoS ONE · 2018 · 17 citations · Full text

Life Sciences, Immunology, Oncology +17

Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy

Yasuhiro Oyama, Hideya Onishi, Satoko Koga et al. · Journal of Immunotherapy · 2019 · 17 citations · Full text

Medicine, Immunology, Oncology +17